Epigenetic determinants of Epstein-Barr virus and cellular DNA in oral diseases

口腔疾病中 Epstein-Barr 病毒和细胞 DNA 的表观遗传决定因素

基本信息

  • 批准号:
    8894306
  • 负责人:
  • 金额:
    $ 57.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-20 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Epstein-Barr virus (EBV) infection of oropharyngeal epithelial cells is associated with at least two types of disease: oral hairy leukoplakia (OHL), a tongue lesion caused by lytic EBV infection of differentiated epithelial cells, and nasopharyngeal carcinoma (NPC), a malignancy characterized by latent EBV infection of undifferentiated epithelial cells. AIDS patients have impaired control of lytic and latent EBV infection and increased incidence of OHL and NPC compared to normal hosts. The two EBV immediate-early proteins, BZLF1 (Z) and BRLF1 (R), promote the switch from latent to lytic EBV infection. Our recent studies have shown DNA methylation of lytic promoters enhances Z, but impedes R activation of lytic infection. Our exciting preliminary data reveal that the newly described epigenetic modification implicated in cytosine demethylation, 5-hydroxymethyl-cytosine (5-hmC), has a profound effect upon the ability of Z versus R to induce lytic EBV reactivation. Although epithelial cell differentiation has been linked to EBV lytic reactivation, studies of this relationship have been limited by the lack of an organotypic in vitro model that stably maintains EBV infection. We recently identified a telomerase immortalized normal oral keratinocyte (NOK) line that can be stably EBV infected, demonstrated that EBV+ NOKs undergo differentiation in raft cultures, and that lytic EBV reactivation occurs specifically in the more differentiated cells To date, EBV+ NOK is the only cell line shown to contain largely unmethylated EBV genomes, and the only EBV+ cell line known to reactivate following R, but not Z, expression. Thus, EBV+ NOKs are a unique tool for understanding the epigenetic mechanisms that link epithelial cell differentiation to the conversion of EBV latent to lytic infection and how EBV latent and lytic gene products influence the epigenetic state of infected oral epithelial cells. In Specific Aim 1, we will characterize the epigenetic modifications of the host and viral genomes that occur during differentiation, and result in lytic reactivation and determine the role of BLIMP1 in reactivating EBV during NOK differentiation. In Specific Aim 2, we will examine the effect of 5-hmC modification on lytic and latent EBV gene expression. In Specific Aim 3, we will use the EBV+ NOK system to examine the effects of LMP1 and LMP2A on epithelial cell differentiation, viral replication, and the epigenetic state of the viral and cellular genomes. In Specific Aim 4, we will characterize the extent of 5-hmC modification in NPC specimens and determine if the 5-hmC pathway is disrupted in NPC tumors. We hypothesize that a) methylation and 5-hmC modification of the EBV genome controls reactivation by Z versus R, b) epithelial differentiation regulates EBV reactivation at least partially via effects on viral genome methylation and 5-hmC modification, and c) EBV+ NPC tumors only occur in undifferentiated epithelial cells that promote viral latency at least partially via viral genome epigenetic modifications. The proposed studies should greatly enhance our understanding of how EBV normally replicates in differentiated epithelial cells yet achieves long term viral latency in undifferentiated epithelial tumor cells.
描述(由申请人提供):口咽上皮细胞的爱泼斯坦 - 巴尔病毒(EBV)感染至少两种疾病:口服毛状白血病(OHL),这种舌头病变是由裂纹EBV引起的,这是由分化的上皮细胞和鼻cho脑脑(NASOPHARYNGELECELCIFCONTIFE)的裂解EBV引起的,一种舌头感染(NASORCHARYNGELNGEAL CARINDIFCONT),一种,一种舌头。上皮细胞。与正常宿主相比,艾滋病患者对裂解和潜在EBV感染的控制受损,OHL和NPC的发病率增加。两种EBV即时蛋白质BZLF1(Z)和BRLF1(R)促进了从潜在的EBV感染转向。我们最近的研究表明,裂解启动子的DNA甲基化增强了Z,但阻碍了裂解感染的R激活。我们令人兴奋的初步数据表明,新描述的表观遗传学修饰与胞嘧啶脱甲基化有关的5-羟基甲基 - 胞嘧啶(5-HMC)对Z与R诱导Lytic EBV耐激活的能力产生了深远的影响。尽管上皮细胞分化与EBV裂解重新激活有关,但对此进行了研究 由于缺乏稳定维持EBV感染的体外模型,关系受到限制。 We recently identified a telomerase immortalized normal oral keratinocyte (NOK) line that can be stably EBV infected, demonstrated that EBV+ NOKs undergo differentiation in raft cultures, and that lytic EBV reactivation occurs specifically in the more differentiated cells To date, EBV+ NOK is the only cell line shown to contain largely unmethylated EBV genomes, and the only EBV+ cell line known to reactivate遵循r,但不是z的表达。因此,EBV+ NOKS是理解将上皮细胞分化与EBV潜伏感染与裂解感染的转化以及EBV潜在和裂解基因产物如何影响感染口腔上皮细胞的表观遗传状态的独特工具。在特定目标1中,我们将表征分化过程中发生的宿主和病毒基因组的表观遗传修饰,并导致裂解重新激活,并确定Blimp1在NOK分化过程中重新激活EBV中的作用。在特定目标2中,我们将研究5-HMC修饰对裂解和潜在EBV基因表达的影响。在特定的目标3中,我们将使用EBV+ NOK系统来检查LMP1和LMP2A对病毒和细胞基因组的上皮细胞分化,病毒复制以及表观遗传状态的影响。在特定目标4中,我们将 表征NPC标本中5-HMC修饰的程度,并确定在NPC肿瘤中是否破坏了5-HMC途径。 We hypothesize that a) methylation and 5-hmC modification of the EBV genome controls reactivation by Z versus R, b) epithelial differentiation regulates EBV reactivation at least partially via effects on viral genome methylation and 5-hmC modification, and c) EBV+ NPC tumors only occur in undifferentiated epithelial cells that promote viral latency at least partially via viral genome epigenetic修改。拟议的研究应大大增强我们对EBV如何在分化的上皮细胞中通常复制但在未分化上皮的长期病毒潜伏期中如何复制的理解 肿瘤细胞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIC C JOHANNSEN其他文献

ERIC C JOHANNSEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIC C JOHANNSEN', 18)}}的其他基金

Role of Epstein-Barr virus LMP2A protein in maintaining oncogenic IgM signaling in EBV+ B cell lymphomas
Epstein-Barr病毒LMP2A蛋白在维持EBV B细胞淋巴瘤中致癌IgM信号传导中的作用
  • 批准号:
    10540952
  • 财政年份:
    2022
  • 资助金额:
    $ 57.89万
  • 项目类别:
Role of Epstein-Barr virus LMP2A protein in maintaining oncogenic IgM signaling in EBV+ B cell lymphomas
Epstein-Barr病毒LMP2A蛋白在维持EBV B细胞淋巴瘤中致癌IgM信号传导中的作用
  • 批准号:
    10707312
  • 财政年份:
    2022
  • 资助金额:
    $ 57.89万
  • 项目类别:
Epigenetic determinants of Epstein-Barr virus and cellular DNA in oral diseases
口腔疾病中 Epstein-Barr 病毒和细胞 DNA 的表观遗传决定因素
  • 批准号:
    8737880
  • 财政年份:
    2013
  • 资助金额:
    $ 57.89万
  • 项目类别:
Epigenetic determinants of Epstein-Barr virus and cellular DNA in oral diseases
口腔疾病中 Epstein-Barr 病毒和细胞 DNA 的表观遗传决定因素
  • 批准号:
    8625514
  • 财政年份:
    2013
  • 资助金额:
    $ 57.89万
  • 项目类别:
Epigenetic determinants of Epstein-Barr virus and cellular DNA in oral diseases
口腔疾病中 Epstein-Barr 病毒和细胞 DNA 的表观遗传决定因素
  • 批准号:
    9113554
  • 财政年份:
    2013
  • 资助金额:
    $ 57.89万
  • 项目类别:
Epigenetic determinants of Epstein-Barr virus and cellular DNA in oral diseases
口腔疾病中 Epstein-Barr 病毒和细胞 DNA 的表观遗传决定因素
  • 批准号:
    9318496
  • 财政年份:
    2013
  • 资助金额:
    $ 57.89万
  • 项目类别:
EBNA-3C in B Lymphocyte Transformation by EBV
EBNA-3C 在 EBV 转化 B 淋巴细胞中的作用
  • 批准号:
    6618097
  • 财政年份:
    2001
  • 资助金额:
    $ 57.89万
  • 项目类别:
EBNA-3C in B Lymphocyte Transformation by EBV
EBNA-3C 在 EBV 转化 B 淋巴细胞中的作用
  • 批准号:
    6532875
  • 财政年份:
    2001
  • 资助金额:
    $ 57.89万
  • 项目类别:
EBNA-3C in B Lymphocyte Transformation by EBV
EBNA-3C 在 EBV 转化 B 淋巴细胞中的作用
  • 批准号:
    6360398
  • 财政年份:
    2001
  • 资助金额:
    $ 57.89万
  • 项目类别:
Core C - Virus Core
核心 C - 病毒核心
  • 批准号:
    10414882
  • 财政年份:
    1997
  • 资助金额:
    $ 57.89万
  • 项目类别:

相似国自然基金

失重对B淋巴细胞免疫应答的影响及其力学生物学机制
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    24 万元
  • 项目类别:
    青年科学基金项目
肠神经胶质细胞对肠B淋巴细胞的影响及其在炎症性肠病发生发展中的作 用
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
肝激酶B1(LKB1)调控脂肪2型天然淋巴细胞(ILC2)的功能影响肥胖及2型糖尿病发生
  • 批准号:
    81971487
  • 批准年份:
    2019
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
Wnt/β-catenin和NF-κB信号串扰在褪黑激素核受体介导单色光影响鸡淋巴细胞增殖中的作用
  • 批准号:
    31873000
  • 批准年份:
    2018
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
结肠癌细胞分泌APRIL对B细胞功能的影响和调控机制的研究
  • 批准号:
    81702405
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 57.89万
  • 项目类别:
The roles of FRCs in HIV-1 spread and establishment of latency
FRC 在 HIV-1 传播和潜伏期建立中的作用
  • 批准号:
    10759591
  • 财政年份:
    2023
  • 资助金额:
    $ 57.89万
  • 项目类别:
Identifying Endogenous Retroviral Factors in Viral Lymphomagenesis
鉴定病毒性淋巴瘤发生中的内源性逆转录病毒因子
  • 批准号:
    10700554
  • 财政年份:
    2023
  • 资助金额:
    $ 57.89万
  • 项目类别:
T-cell activation and exhaustion in the HIV-positive female genital tract
HIV 阳性女性生殖道中 T 细胞的激活和耗竭
  • 批准号:
    10704271
  • 财政年份:
    2023
  • 资助金额:
    $ 57.89万
  • 项目类别:
Oral transmission of KSHV using rhesus macaque rhadinovirus model
使用恒河猴鼻病毒模型经口传播 KSHV
  • 批准号:
    10541061
  • 财政年份:
    2022
  • 资助金额:
    $ 57.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了